Fingerprint
Dive into the research topics of 'Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically